Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex^® 10% Versus Gammaplex^® 5% in Subjects with Primary Immunodeficiency.

Wasserman, Richard L; Melamed, Isaac R; Stein, Mark R; Jolles, Stephen; Norton, Miranda; Moy, James N.

J Clin Immunol ; 37(3): 301-310, 2017 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-28316003

2.

Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency.

Wasserman, Richard L; Melamed, Isaac; Stein, Mark R; Engl, Werner; Sharkhawy, Marlies; Leibl, Heinz; Puck, Jennifer; Rubinstein, Arye; Kobrynski, Lisa; Gupta, Sudhir; Grant, Andrew J; Ratnayake, Anoshie; Richmond, Wendell G; Church, Joseph; Yel, Leman; Gelmont, David.

J Clin Immunol ; 36(6): 571-82, 2016 08.

Artigo em Inglês | MEDLINE | ID: mdl-27220317

3.

Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency.

Wasserman, Richard L; Melamed, Isaac; Stein, Mark R; Gupta, Sudhir; Puck, Jennifer; Engl, Werner; Leibl, Heinz; McCoy, Barbara; Empson, Victoria G; Gelmont, David; Schiff, Richard I.

J Allergy Clin Immunol ; 130(4): 951-7.e11, 2012 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-22846381

4.

Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency.

Wasserman, Richard L; Melamed, Isaac R; Stein, Mark R; Jolles, Stephen; Norton, Miranda; Moy, James N.

J Clin Immunol ; 37(6): 613, 2017 08.

Artigo em Inglês | MEDLINE | ID: mdl-28714047

5.

Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency disease.

Wasserman, Richard L; Melamed, Isaac; Kobrynski, Lisa; Strausbaugh, Steven D; Stein, Mark R; Sharkhawy, Marlies; Engl, Werner; Leibl, Heinz; Sobolevsky, Luba; Gelmont, David; Schiff, Richard I; Grossman, William J.

J Clin Immunol ; 31(3): 323-31, 2011 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-21424824

6.

20% subcutaneous immunoglobulin dosed biweekly for primary immunodeficiency.

Wasserman, Richard L; Stein, Mark R; Younger, M Elizabeth M; Fatteh, Shahnaz; Haddad, Elie.

Ann Allergy Asthma Immunol ; 117(1): 93-4, 2016 07.

Artigo em Inglês | MEDLINE | ID: mdl-27236217

7.

Tolerability of a new 10% liquid immunoglobulin for intravenous use, Privigen, at different infusion rates.

Sleasman, John W; Duff, Carla M; Dunaway, Theresa; Rojavin, Mikhail A; Stein, Mark R.

J Clin Immunol ; 30(3): 442-8, 2010 May.

Artigo em Inglês | MEDLINE | ID: mdl-20217199

8.

Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies.

Stein, Mark R; Nelson, Robert P; Church, Joseph A; Wasserman, Richard L; Borte, Michael; Vermylen, Christiane; Bichler, Johann.

J Clin Immunol ; 29(1): 137-44, 2009 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-18814020

9.

Immune globulin subcutaneous, human - klhw 20% for primary humoral immunodeficiency: an open-label, Phase III study.

Sleasman, John W; Lumry, William R; Hussain, Iftikhar; Wedner, H James; Harris, James B; Courtney, Kecia L; Mondou, Elsa; Lin, Jiang; Stein, Mark R.

Immunotherapy ; 11(16): 1371-1386, 2019 11.

Artigo em Inglês | MEDLINE | ID: mdl-31621458

10.

Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy.

Koterba, Alan P; Stein, Mark R.

Allergy Asthma Clin Immunol ; 11(1): 63, 2015.

Artigo em Inglês | MEDLINE | ID: mdl-25535489

11.

Possible mechanisms of influence of esophageal acid on airway hyperresponsiveness.

Stein, Mark R.

Am J Med ; 115 Suppl 3A: 55S-59S, 2003 Aug 18.

Artigo em Inglês | MEDLINE | ID: mdl-12928076

12.

Clinical immunology in practice, new opportunities.

Stein, Mark R.

Clin Rev Allergy Immunol ; 27(2): 83-91, 2004 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-15576892

13.

Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases.

Stein, Mark R; Koterba, Alan; Rodden, Linda; Berger, Melvin.

Postgrad Med ; 123(5): 186-93, 2011 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-21904101

14.

New Frontiers in Subcutaneous Immunoglobulin Treatment.

Jolles, Stephen; Stein, Mark R; Longhurst, Hilary J; Borte, Michael; Ritchie, Bruce; Sturzenegger, Matthias H; Berger, Melvin.

Biol Ther ; 1: 3, 2011.

Artigo em Inglês | MEDLINE | ID: mdl-24392293

15.

Pharmacokinetics of subcutaneous IgPro20 in patients with primary immunodeficiency.

Wasserman, Richard L; Melamed, Isaac; Nelson, Robert P; Knutsen, Alan P; Fasano, Mary Beth; Stein, Mark R; Rojavin, Mikhail A; Church, Joseph A.

Clin Pharmacokinet ; 50(6): 405-14, 2011 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-21553933

16.

The new generation of liquid intravenous immunoglobulin formulations in patient care: a comparison of intravenous immunoglobulins.

Stein, Mark R.

Postgrad Med ; 122(5): 176-84, 2010 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-20861601

17.

Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.

Wasserman, Richard L; Church, Joseph A; Peter, Hans H; Sleasman, John W; Melamed, Isaac; Stein, Mark R; Bichler, Johann.

Eur J Pharm Sci ; 37(3-4): 272-8, 2009 Jun 28.

Artigo em Inglês | MEDLINE | ID: mdl-19491015

18.

Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial.

Kiljander, Toni O; Harding, Susan M; Field, Stephen K; Stein, Mark R; Nelson, Harold S; Ekelund, Jan; Illueca, Marta; Beckman, Ola; Sostek, Mark B.

Am J Respir Crit Care Med ; 173(10): 1091-7, 2006 May 15.

Artigo em Inglês | MEDLINE | ID: mdl-16357331

19.

Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency.

Church, Joseph A; Leibl, Heinz; Stein, Mark R; Melamed, Isaac R; Rubinstein, Arye; Schneider, Lynda C; Wasserman, Richard L; Pavlova, Borislava G; Birthistle, Karl; Mancini, Marianne; Fritsch, Sandor; Patrone, Lisa; Moore-Perry, Kerry; Ehrlich, Hartmut J.

J Clin Immunol ; 26(4): 388-95, 2006 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-16705486

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex^® 10% Versus Gammaplex^® 5% in Subjects with Primary Immunodeficiency.

Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency.

Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency.

Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency.

Efficacy, safety, and pharmacokinetics of a 10% liquid immune globulin preparation (GAMMAGARD LIQUID, 10%) administered subcutaneously in subjects with primary immunodeficiency disease.

20% subcutaneous immunoglobulin dosed biweekly for primary immunodeficiency.

Tolerability of a new 10% liquid immunoglobulin for intravenous use, Privigen, at different infusion rates.

Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies.

Immune globulin subcutaneous, human - klhw 20% for primary humoral immunodeficiency: an open-label, Phase III study.

Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy.

Possible mechanisms of influence of esophageal acid on airway hyperresponsiveness.

Clinical immunology in practice, new opportunities.

Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases.

New Frontiers in Subcutaneous Immunoglobulin Treatment.

Pharmacokinetics of subcutaneous IgPro20 in patients with primary immunodeficiency.

The new generation of liquid intravenous immunoglobulin formulations in patient care: a comparison of intravenous immunoglobulins.

Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.

Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial.

Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency.